[1] Baijal R, Amarapurkar D, Praveen Kumar HR, et al. Amulticenter prospective study of infections related morbidity and mortality in cirrhosis of liver. Indian J Gastroenterol,2014,33: 336-342.
[2] Oey RC,Kuiper JJ,van Buuren HR,et al. Reagent strips are efficient to rule out spontaneous bacterial peritonitis in cirrhotics. Neth J Med,2016,74: 257-261.
[3] DeMattos AA, Costabeber AM, Lionco LC, et al. Multiresistant bacteria in spontaneous bacterial peritonitis: a new step in management? World J Gastroenterol, 2014,20: 14079-14086.
[4] Danulescu RM, Stanciu C, Trifan A. Evaluation of prognostic factors in decmpensated liver cirrhosis with ascites and spontaneous bacterial peritonitis. Rev Med Chir Soc Med Nat Iasi, 2015,119: 1018-1024.
[5] Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology, 2005,41: 422-433.
[6] 宋媛媛,江宇泳.自发性细菌性腹膜炎诊断与治疗的研究进展. 临床肝胆病杂志,2016,32:1188-1191.
[7] Angeloni S, Leboffe C, Parente A, et al. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol, 2008, 14: 2757-2762.
[8] Runyon BA, Shuhart MC, Davis GL,et al.Management of adult patients with ascites due to cirrhorsis: an update.Hepatology,2009,49: 2087-2107.
[9] 张燕, 王全楚,李娜.血清PCT检测在肝硬化合并自发性细菌性腹膜炎分级诊疗中的应用价值. 胃肠病学和肝病学杂志, 2016. 25: 663-665.
[10] Kadam N, Acharya S,Shukla S,et al.Ascitic Fluid High Sensitive C-Reactive Protein (hs-CRP). A Prognostic Marker in Cirrhosis with Spontaneous Bacterial Peritonitis.J Clin Diagn Res,2016,10: OC20-OC24.
[11] 叶丽君,喻长法,段达荣,等.16S rRNA 基因检测在自发性腹膜炎快速诊断中的应用价值.中国卫生检验杂志,2015,25: 1978-1979,1993.
[12] Agiasotelli D,Alexopoulou A,Vasilieva L,et al. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis. Liver Int, 2017;37: 576-582.
[13] Assem M,Elsabaawy M,Abdelrashed M,et al.Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study. Hepatol Int, 2016. 10: 377-385.
[14] 邓媛.廖毅慢性肝炎肝硬化腹水并发自发性细菌性腹膜炎相关危险因素分析.中国基层医药.2011.18:2182-2183.
[15] Salerno F,Lamura V.Treatment of spontaneous bacterial peritonitis.Dig Dis,2015, 33: 582-585.
[16] 居朝霞,陈菊娣,周美芳,等.腹腔置管灌洗治疗肝硬化自发性细菌性腹膜炎疗效观察. 实用肝脏病杂志, 2016. 19: 482-483.
[17] Mandorfer M,Bota S,Schwabl P,et al.Nonselective b blockers increase risk for hepatorenal syndrome and death in patients with cirrhosisand spontaneous bacterial peritonitis. Gastroenterology, 2014,146: 1680-1690.
[18] Jacobs C,Coss Adame E,Attaluri A,et al. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth. Aliment Pharmacol Ther, 2013,37: 1103-1111.
[19] Abu-Amer Y,Bar-Shavit Z. Impaired bone marrowderived macrophage differentiation in vitamin D defi-ciency. Cell Immunol,1993,151: 356-368.
[20] Zhang C, Zhao L, Ding Y,et al. Enhanced LL-37 expression following vitamin D supplementation in patients with cirrhosis and spontaneous bacterial peritonitis patients with cirrhosis and spontaneous bacterial peritonitis:Liver Int,2016,36: 68-75. |
